Quarterly report pursuant to Section 13 or 15(d)

SHARE PURCHASE WARRANTS

v3.20.1
SHARE PURCHASE WARRANTS
6 Months Ended
Feb. 29, 2020
Share Purchase Warrants [Abstract]  
SHARE PURCHASE WARRANTS

18.

SHARE PURCHASE WARRANTS

 

Share purchase warrants outstanding as at February 29, 2020 are:

 

Expiry Date   Exercise Price     Warrants Outstanding  
March 9, 2020   US$ 1.50       114,678  
May 22, 2020   US$ 0.28       678,571  
May 22, 2020   US$ 0.30       1,554,165  
June 7, 2020   US$ 0.525       1,190,476  
June 14, 2020   US$ 1.50       329,080  
July 5, 2020   US$ 0.35       200,000  
July 5, 2020   US$ 0.30       200,000  
July 26, 2020   US$ 1.50       1,637,160  
August 16, 2020   US$ 0.22       352,940  
August 28, 2020   US$ 0.94       1,311,242  
August 28, 2020   US$ 1.00       246,913  
August 28, 2020   US$ 1.50       35,714  
August 29, 2020   US$ 0.15       2,666,666  
September 6, 2020   US$ 1.01       925,925  
October 11, 2020   US$ 1.35       510,204  
October 11, 2020   US$ 1.50       10,204  
October 19, 2020   US$ 0.24       1,315,789  
October 29, 2020   US$ 0.18       555,555  
November 7, 2020   US$ 0.61       20,408  
November 7, 2020   US$ 0.66       300,000  
November 8, 2020   US$ 1.01       918,355  
December 7, 2020   US$ 0.67       185,185  
December 7, 2020   US$ 1.50       3,188,735  
December 17, 2020   US$ 0.26       952,380  
January 10, 2021   US$ 1.50       1,437,557  
January 11, 2021   US$ 1.50       307,692  
January 14, 2021   US$ 0.20       1,176,470  
January 16, 2021   US$ 0.14       357,142  
Mar 29, 2021   US$ 0.465       1,481,481  
April 8, 2021   CAD$ 4.73       57,756  
May 22, 2021   US$ 0.91       6,000,000  
May 22, 2021   US$ 0.30       1,133,333  
May 22, 2021   US$ 1.50       65,759  
July 5, 2021   US$ 0.25       52,631  
July 5, 2021   US$ 0.28       131,578  
July 5, 2021   US$ 0.35       3,917,771  
August 16, 2021   CAD$ 0.29       120,000  
August 16, 2021   US$ 0.18       4,210,785  
September 20, 2021   US$ 0.23       1,111,111  
September 30, 2021   US$ 0.23       2,777,777  
November 26, 2023   US$ 0.17       1,683,230  
December 4, 2023   US$ 0.17       2,286,720  
              47,709,138  
Weighted average remaining contractual life             1.19 years  
Weighted average exercise price   USD$ 0.59          

  

Warrants exercisable for 25,327 common shares at an exercise price of CAD$28.35 and warrants exercisable for 1,618,356 common shares at exercise prices ranging from $0.86 to $1.10 per share expired during the three months ended November 30, 2019.

Warrants exercisable for 282,193 common shares at an exercise price of US$0.37 expired during the three months ended February 29, 2020.

From September 17, 2019 to October 29, 2019, the Company issued warrants exercisable for 4,367,635 common shares at exercise prices ranging from $0.17 to $0.26 per share, to convertible debt note holders in terms of subscription unit agreements entered into with the convertible note holders (Note 13(g) to 13 (l)). The fair value of the warrants granted was estimated using the relative fair value method at between $0.05 to $0.09 per warrant.

From December 4, 2019 to January 16, 2021, the Company issued warrants exercisable for 2,643,862 common shares at exercise prices ranging from $0.17 to $0.14 per share, to convertible debt note holders in terms of subscription unit agreements entered into with the convertible note holders (Note 13(r) and 13 (o)). The fair value of the warrants granted was estimated using the relative fair value method at between $0.03 to $0.08 per warrant.

On September 19, 2019, the Company issued warrants exercisable for 1,111,111 common shares in terms of a debt settlement agreement entered into with Calvary fund LP. (Note 13(b)). The warrants are exercisable at $0.23 per share. The fair value of the warrants granted was estimated using the relative fair value method at $0.07 per share.

On September 30, 2019, the Company issued warrants exercisable over 2,777,777 common shares in terms of a subscription agreement entered into with an investor. The warrants are exercisable at $0.23 per share. The fair value of the warrants granted was estimated using the relative fair value method at $0.06 per share.

The share purchase warrants issued, during the six months ended February 29, 2020, were valued at $744,865 using the relative fair value method. The fair value of share purchase warrants were estimated using the Black-Scholes valuation model utilizing the following weighted average assumptions:

    Six months ended
February 29,
2020
 
Share price   CAD$ 0.21 to 0.385  
Exercise price   CAD$ 0.22 to 0.34  
Expected share price volatility    

99.7% to 127.9

%
Risk-free interest rate    

1.49% to 1.72%

%
Expected term    

1—4 years